Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value

Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value GlobeNewswire November 11, 2025 Confirms Receipt of Unsolicited Indication of Interest and Director Nominations from Lynx1 Master Fund LP No Stockholder Action Required at This Time BURLINGTON, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) — Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) (Nasdaq: NEUP), a clinical-stage […]

Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement

Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement GlobeNewswire November 11, 2025 REDWOOD CITY, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that its Board of Directors has authorized a share repurchase and

Aya Gold & Silver Reports Record Revenue and Net Income for Q3-2025 on Record Production

Aya Gold & Silver Reports Record Revenue and Net Income for Q3-2025 on Record Production GlobeNewswire November 11, 2025 MONTREAL, Nov. 11, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) today announced third quarter financial and operational results for the three-month period ended September 30, 2025.

New Peer-Reviewed Publications Highlight Effectiveness of OMNI(R) Surgical System with TruSync(TM) Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans

New Peer-Reviewed Publications Highlight Effectiveness of OMNI(R) Surgical System with TruSync(TM) Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans Prospective study data and retrospective registry data were analyzed in the manuscripts recently published by the Journal of Cataract and Refractive Surgery, Journal of Glaucoma and Clinical

Cibus Announces the Election of Craig Wichner to Board of Directors

Cibus Announces the Election of Craig Wichner to Board of Directors Appointment underscores company's commitment to long-term shareholder value creation and sustained business growth GlobeNewswire November 11, 2025 SAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today

Nevada Lithium Applauds Boron’s Addition to 2025 US Critical Minerals List

Nevada Lithium Applauds Boron's Addition to 2025 US Critical Minerals List GlobeNewswire November 11, 2025 VANCOUVER, British Columbia, Nov. 11, 2025 (GLOBE NEWSWIRE) — Nevada Lithium Resources Inc. (TSXV: NVLH; OTCQB: NVLHF; FSE: 87K) (“Nevada Lithium” or the “Company“) is pleased to announce that it has learned that boron has joined lithium on the Final

Pasinex Receives MAPEG Approval for Sarikaya Zinc Project; Outlines Near-Term Development Plan

Pasinex Receives MAPEG Approval for Sarikaya Zinc Project; Outlines Near-Term Development Plan GlobeNewswire November 11, 2025 TORONTO, Nov. 11, 2025 (GLOBE NEWSWIRE) — Pasinex Resources Limited (CSE: PSE; FSE: PNX) (“Pasinex” or the “Company“) today announced that Turkiye's General Directorate of Mining and Petroleum Affairs (“MAPEG“) has approved the transfer of shares in Aydın Teknik

Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference

Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference GlobeNewswire November 11, 2025 FRIENDSWOOD, Texas, Nov. 11, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the

Calian Group Announces Governance Changes to Support Strategic Operations Following Agreement with Plantro Ltd.

Calian Group Announces Governance Changes to Support Strategic Operations Following Agreement with Plantro Ltd. GlobeNewswire November 11, 2025 – Enters co-operation agreement with Plantro Ltd.– Accelerates ongoing board renewal process– Forms special committee to oversee the execution of actions related to non-core assets, to include participation by special advisor recommended by Plantro OTTAWA, Ontario, Nov.

Solesence Reports Third Quarter 2025 Financial Results

Solesence Reports Third Quarter 2025 Financial Results GlobeNewswire November 11, 2025 Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) — Solesence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the

Scroll to Top